title: Treatment of acute bleeding episodes with rFVIIa.
authors.affiliation: Department of Clinical Immunology, Centre for Haemophilia and Thrombosis, and Departments of Orthopedic Surgery and Oral and Maxillofacial Surgery, University Hospital Aarhus, Denmark. j-ing@post3.tele.dk
authors.forename: J
authors.initials: J
authors.lastname: Ingerslev
authors.forename: O
authors.initials: O
authors.lastname: Sneppen
authors.forename: I
authors.initials: I
authors.lastname: Hvid
authors.forename: U
authors.initials: U
authors.lastname: Fredberg
authors.forename: H L
authors.initials: HL
authors.lastname: Kristensen
authors.forename: S
authors.initials: S
authors.lastname: Sindet-Petersen
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D019468:Disease Management; D015942:Factor VIIa / Q000037:antagonists & inhibitors / Q000276:immunology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006487:Hemostasis / Q000187:drug effects; D006760:Hospitalization; D006801:Humans; D007518:Isoantibodies / Q000009:adverse effects / Q000097:blood; D008875:Middle Aged; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D012189:Retrospective Studies; D012646:Self Administration; D012648:Self Care; D013514:Surgical Procedures, Operative / Q000009:adverse effects
chemical_list: D007518:Isoantibodies; D011994:Recombinant Proteins; D015942:Factor VIIa